Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/1997
03/26/1997EP0764204A1 HUMAN OXALYL-CoA DECARBOXYLASE
03/26/1997EP0764021A1 Uterine fibroid treatment
03/26/1997CN1146202A Quinolone derivative for treatment of urinary incontinence
03/26/1997CN1145899A Substituted guanidine cinnamate, its prepn., its application as medicine or diagnosing agent and medicine containing the compound
03/26/1997CN1145896A New alkoxyaryl compounds, their process of preparation and pharmaceutical compositions which contain them
03/26/1997CN1145788A Plaster Bishangao for treating hernia
03/25/1997US5614208 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol
03/20/1997WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases
03/20/1997WO1997009980A1 Pharmaceutical formulations containing darifenacin
03/20/1997WO1997006807A3 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation
03/19/1997EP0763035A1 Endothelin receptor antagonists
03/19/1997CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity
03/19/1997CN1145360A Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same
03/19/1997CN1145223A Endothelin receptor antagonists
03/18/1997US5612360 Aromatic n-heterocyclic compounds as hypotensive agents with acid groups, sulfonylcarboxamides or tetrazole groups
03/18/1997US5612359 Substituted biphenyl isoxazole sulfonamides
03/18/1997US5612351 Azabicyclic derivatives of 1,2,3-oxa(or thia)diazole
03/18/1997US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms
03/18/1997US5612320 Blends of dextrose, dextrin, maltodextrin with water
03/18/1997US5612314 Nitrosylated neuropeptides
03/13/1997WO1997009311A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
03/13/1997WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract
03/13/1997WO1997002826A3 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients
03/12/1997EP0761684A2 Alanine substitution analogues of magainin peptides
03/12/1997EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments
03/12/1997EP0761204A1 Use of extracts of filamentous, non photosynthetic bacteria and the composition containing them
03/12/1997EP0760811A1 Imidazole derivatives as histamine receptor h 3? (ant)agonists
03/12/1997EP0760672A1 Angiotensin ii for improving fertilization
03/12/1997EP0760668A1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
03/12/1997EP0760664A1 Use of pteridine derivatives as no-synthase inhibitors
03/12/1997EP0760661A1 Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
03/12/1997EP0693059B1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same
03/12/1997EP0422100B1 11 beta-substituted progesterone analogs
03/12/1997CN1145075A Antagonist's of endothelin receptors
03/12/1997CN1145027A Use of insulin sensitisers for treating renal diseases
03/12/1997CN1144801A Beta-Adrenergic agonists
03/12/1997CN1144800A 3-substituted oxindole derivatives as potassium channel modulators
03/11/1997US5610167 Methods of inhibiting atrophy of the skin and vagina
03/11/1997US5610153 Benzazepinone derivatives
03/11/1997US5610138 Mixture of gonadotrophins and growth hormone
03/11/1997US5610136 Administering chorionic gonadotropin
03/11/1997CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels
03/06/1997WO1997008166A1 Piperazino derivatives as neurokinin antagonists
03/06/1997WO1997008159A1 1(hetero)aryl-4-(condensed thiazol-2-ylalkyl)-piperazine derivatives, their preparation and their use in the treatment of 5-ht1a-receptor mediated disorders
03/05/1997EP0759983A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
03/05/1997EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/05/1997EP0759741A1 Mucoadhesive emulsions containing cyclodextrin
03/05/1997CN1144486A Treatment of ovarian estrogen dependent conditions
03/05/1997CN1144485A Adhesion inhibiting composition
03/05/1997CN1144128A Pure traditional Chinese medicinal liquor with antisenile action
03/05/1997CN1144107A Cuyunyifuling plaster
03/05/1997CN1144089A Water-soluble gossypol preparation and its preparing method
03/05/1997CN1034171C 4-pyrimdinone derivatives, their preparation and their application in therapy
03/04/1997US5607978 Prostaglandins for vision defects
03/04/1997US5607934 Preventing and treating diseases caused by superoxide radicals, nephritis
02/1997
02/27/1997WO1997007399A1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules
02/27/1997WO1997007120A1 Biphenyl(thio)amide and biphenylethan(thi)one derivatives, their preparation and their use as 5-ht1d receptor antagonists
02/27/1997WO1997006807A2 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation
02/27/1997WO1997006797A1 Endometrial ablation using photodynamic therapy with green porphyrins
02/27/1997WO1997006796A1 Benzothiophene compounds
02/27/1997WO1997006793A1 Non-steroidal sulfatase inhibitor compounds and their method of use
02/27/1997WO1996022095A3 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
02/27/1997CA2229662A1 Endometrial ablation using photodynamic therapy with green porphyrins
02/27/1997CA2229554A1 Non-steroidal sulfatase inhibitor compounds and their method of use
02/26/1997EP0759434A1 Benzothiophene compounds
02/26/1997EP0759077A1 Lanthionine-containing antimicrobial compound
02/26/1997EP0759067A1 Transforming growth factor alpha h1
02/26/1997EP0759027A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
02/26/1997EP0758904A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
02/26/1997EP0758895A1 Dosage forms and method for ameliorating male erectile dysfunction
02/26/1997EP0758894A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
02/26/1997EP0705266B1 Process for producing imidazole derivative
02/26/1997CN1143967A Method for variation of chromatin condensation
02/26/1997CN1143963A Tetracyclic derivatives, process of preparation and use
02/26/1997CN1143910A Chemical castration
02/26/1997CN1143908A Treatment of diabetic nephropathy with valsartan
02/26/1997CN1143644A N-|(1,4-diazadicyclo |2,2,2¨ oct -2-yl methyl¨ benzoic amide derivatives, its preparing process and medicinal use
02/26/1997CN1034123C Calcium channel blocking polypeptides from filistate hibernalis
02/25/1997US5605930 Compositions and methods for treating and preventing pathologies including cancer
02/25/1997US5605929 Methods and compositions for inhibiting 5α-reductase activity
02/25/1997US5605909 Substituted N-heteroaryl-1,2-diaminocyclobutene-3,4-dione compounds
02/25/1997US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites
02/25/1997CA2030396C 5-[1-(imidazol)methyl]-3,3-disubstituted-2(3h)furanone derivatives
02/25/1997CA1338940C Ó,ó-disubstituted n-cycloalkylalkylbenzylamines, process for their preparation, their use as a medicament and their synthesis intermediates
02/20/1997WO1997006140A1 Acylated derivatives of melatonin and its analogues, useful as medicaments
02/20/1997DE19531936A1 Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend Combination product for contraception, kits containing them and a method using these
02/19/1997EP0758650A1 Endothelin receptor antagonists
02/19/1997EP0758648A1 Substituted 4H-pyrans with a modulating effect on calcium channels
02/19/1997EP0758644A1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
02/19/1997EP0758452A1 Modulators of cytokines of the tgf-beta superfamily and methods for assaying for same
02/19/1997EP0758234A1 Method and composition for treating renal disease and failure
02/19/1997CN1143386A Transforming growth factor alpha-H1
02/19/1997CN1142970A Cistanche deserticola wine and its preparing method
02/19/1997CN1142962A Nourishing yin and strengthening kidney pill
02/19/1997CN1034077C Preparation of new pyrido|2,3-f¨|1,4¨ thiazepines
02/18/1997US5604261 Having hydroxyl/alkoxyl group ortho to amide group on phenyl ring; high melatonin receptor affinity
02/18/1997US5604248 Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
02/18/1997US5604236 Beta-carboline thromboxane synthase inhibitors
02/18/1997US5604221 Treating congestive heart failure, irritable bowel syndrome
02/18/1997US5604103 Kit for detection of clinical marker in kidney stone disease